Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Nts45 Regulatory News (33JE)

Share Price Information for Barclays Nts45 (33JE)

Share Price is delayed by 15 minutes
Get Live Data
284.95034    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
33JE Live PriceLast checked at - London Stock Exchange

Intraday Barclays Nts45 Share Chart

Stabilisation Notice

15 Jun 2023 14:21

RNS Number : 8868C
Barclays Bank PLC
15 June 2023
 

 

Post-Stabilisation Period Announcement (No Stabilisation)

 

 

08/06/2023

 

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

Lottomatica S.p.A.

 

Post-Stabilisation Period Announcement

 

Further to the pre-stabilisation period announcement dated 16th May 2023, Barclays Bank PLC ('Barclays'), Jan Werner; telephone: +44 (0) 203 555 9753) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation including as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and the UK Market Abuse Regulation) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

 

The securities:

Issuer:

Lottomatica S.p.A.

Guarantor (if any):

The Notes will not be guaranteed on the Issue Date

Aggregate nominal amount/Offering size

€565,000,000

Description:

€565,000,000 7.125% Senior Secured Notes due 2028

Stabilisation:

Stabilisation Manager(s):

Barclays Bank PLC

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the 'Securities Act'), or under the securities laws of any state or other jurisdiction of the United States. Accordingly, the securities referred to herein may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, in or into, the United States absent registration under, or pursuant to an exemption from, the registration requirements of the Securities Act and in compliance with any relevant state securities laws. There will be no public offer of securities in the United States.

 

 

 

 

 

Barclays is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority, is acting for the Issuer only in connection with the offer and will not be responsible to anyone other than the Issuer for providing the protections offered to clients of Barclays, nor for providing advice in relation to the offer or any matters referred to in this communication.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAGZGMVFKNGFZM
Date   Source Headline
19th Sep 20243:15 pmRNSPublication of Final Terms
19th Sep 20243:09 pmRNSPublication of Final Terms
19th Sep 202410:40 amRNSPublication of Final Terms
19th Sep 202410:36 amRNSPublication of Final Terms
17th Sep 20247:00 amRNSPublication of Final Terms
16th Sep 20244:31 pmRNSPublication of Final Terms
16th Sep 20243:03 pmRNSPublication of Final Terms
12th Sep 20249:32 amRNSPublication of Final Terms
6th Sep 20243:56 pmRNSPublication of Final Terms
6th Sep 20243:52 pmRNSPublication of Final Terms
3rd Sep 20243:44 pmRNSPublication of Final Terms
3rd Sep 20243:44 pmRNSPublication of Final Terms
2nd Sep 20245:21 pmRNSPublication of Final Terms
2nd Sep 20245:09 pmRNSPublication of Final Terms
28th Aug 202411:33 amRNSPublication of Final Terms
27th Aug 20242:23 pmRNSPublication of Final Terms
15th Aug 202410:40 amRNSPublication of Final Terms
9th Aug 20245:05 pmRNSPublication of Final Terms
8th Aug 20245:35 pmRNSPublication of Final Terms
8th Aug 20241:28 pmRNSPublication of Final Terms
8th Aug 20241:11 pmRNSPublication of Final Terms
8th Aug 20241:10 pmRNSPublication of Final Terms
8th Aug 20241:09 pmRNSPublication of Final Terms
8th Aug 202412:16 pmRNSPublication of Final Terms
8th Aug 20247:00 amRNSPublication of Final Terms
7th Aug 202412:18 pmRNSPublication of Final Terms
7th Aug 202412:15 pmRNSPublication of Final Terms
7th Aug 202412:14 pmRNSPublication of Final Terms
6th Aug 20244:36 pmRNSPublication of Final Terms
6th Aug 20244:17 pmRNSPublication of Final Terms
1st Aug 20247:00 amRNSHalf-year Report
19th Jul 202410:36 amRNSDirectorate Change
2nd Jul 20242:52 pmRNSPublication of Final Terms
2nd Jul 202411:08 amRNSPublication of Final Terms
25th Jun 20247:00 amRNSPublication of Final Terms
25th Jun 20247:00 amRNSPublication of Final Terms
21st Jun 202412:10 pmRNSPublication of Final Terms
30th May 20244:45 pmRNSSale of shares in Alfa Financial Software Holdings
22nd May 20242:17 pmRNSPublication of Final Terms
17th May 20245:05 pmRNSPublication of Base Prospectus Supplement
15th May 20249:58 amRNSPublication of Final Terms
14th May 20244:32 pmRNSPublication of Final Terms
13th May 20244:43 pmRNSPublication of Final Terms
13th May 20244:17 pmRNSPublication of Final Terms
9th May 20245:30 pmRNSBoard Committee Change
25th Apr 20247:00 amRNSPublication of Pillar 3 report Q1 2024
12th Apr 20243:13 pmRNSApproval of Barclays Bank PLC PSL Base Prospectus
6th Mar 20243:51 pmRNSPublication of Final Terms
21st Feb 20246:23 pmRNSAnnual Financial Report on Form 20-F
20th Feb 20247:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.